Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium lactate + potassium chloride + sodium chloride + calcium chloride + dextrose is a marketed intravenous crystalloid combination solution known as Lactated Ringer's and 5% Dextrose Injection. It is a **small molecule electrolyte and carbohydrate replacement product** used as a source of water, electrolytes, and calories and as an alkalinizing agent in adults and pediatric patients. The solution replenishes extracellular fluid and electrolytes, provides dextrose as a limited caloric substrate, and supplies lactate, which is metabolized to bicarbonate and can help buffer metabolic acidosis. Publicly described products have been developed and manufactured by Hospira, and the product is used clinically for parenteral replacement of extracellular fluid and electrolyte losses when intravenous support is needed.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium lactate + potassium chloride + sodium chloride + calcium chloride + dextrose.